dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
Published 8 years ago • 318 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
20:59
new targets for the treatment of urothelial cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
2:51
fda approves new bladder cancer drug | dr. daniel petrylak
-
16:25
new targets for advanced bladder cancer
-
0:57
dr. petrylak on the keynote-045 trial for urothelial carcinoma
-
1:29
dr. daniel petrylak on the imvigor study of atezolizumab in advanced bladder cancer
-
0:50
dr. petrylak on atezolizumab in bladder cancer
-
1:41
dr. petrylak on immunotherapy for second-line treatment in bladder cancer
-
1:05
dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
1:08
dr. petrylak on the future immunotherapy in bladder cancer
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:06
dr. petrylak discusses bcg for the treatment of patients with non-invasive bladder cancer
-
0:34
dr. petrylak discusses custirsen as a potential treatment for prostate cancer
-
3:03
daniel petrylak, md, discusses the role of checkpoint inhibition therapy in urothelial carcinoma
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
1:11
daniel petrylak, md, on treating bladder cancer patients progressing on checkpoint inhibitors